BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/28/2026 10:31:08 AM | Browse: 24 | Download: 7
Publication Name World Journal of Translational Medicine
Manuscript ID 126295
DOI 10.5528/wjtm.126295
Country Greece
Category Oncology
Manuscript Type Systematic Reviews
Article Title Prognostic biomarkers for pancreatic ductal adenocarcinoma: A contemporary systematic review and modelling study
Manuscript Source Unsolicited Manuscript
All Author List Vassiliki Tarara, Eleftherios Panteris, Sotirios Varlamis, Eleni Andreadou, Ilias Pessach, Matthaios Bobos, Maria Chatzidimitriou, Stella Mitka, Androniki Papoutsi, Phaedra Eleftheriou, Petros Skepastianos and Evangelos Karamitrousis
Funding Agency and Grant Number
Corresponding Author Evangelos Karamitrousis, Assistant Professor, Department of Biomedical Sciences, International Hellenic University, Alexandria Campus, Sindos, Thessaloniki 57400, Kentrikí Makedonía, Greece. karamitrousis@ihu.gr
Key Words Pancreatic ductal adenocarcinoma; Prognostic biomarkers; Proteomics; Survival analysis; Transcriptomics
Core Tip This study integrates a contemporary systematic review with exploratory modelling to examine why prognostic biomarker discovery in pancreatic ductal adenocarcinoma has not translated into clinical practice. Although numerous tumor-derived transcriptomic and proteomic biomarkers showed independent survival associations, robust external validation and incorporation into clinical trials remained uncommon. An exploratory 5-gene molecular signature showed a strong survival association but only modest discrimination in the derivation cohort, and its continuous risk score failed external validation. These findings highlight reproducibility, prespecified validation, and biomarker-guided trial design as priorities for clinically useful pancreatic ductal adenocarcinoma risk stratification.
Citation Tarara V, Panteris E, Varlamis S, Andreadou E, Pessach I, Bobos M, Chatzidimitriou M, Mitka S, Papoutsi A, Eleftheriou P, Skepastianos P, Karamitrousis E. Prognostic biomarkers for pancreatic ductal adenocarcinoma: A contemporary systematic review and modelling study. World J Transl Med 2026; In press
PDF 126295-in-press.pdf
Received
2026-07-30 03:35
Peer-Review Started
2026-08-05 00:52
First Decision by Editorial Office Director
Return for Revision
2026-08-27 06:48
Revised
2026-09-20 12:20
Publication Fee Transferred
Second Decision by Editor
2026-10-28 07:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-10-28 10:31
Articles in Press
2026-10-28 10:31
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-6132 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com